Given Progressives and Muslims antipathy to all things Israeli, I would hope so:
Vaxil BioTherapeutics's ImMucin trains immune system to fight cancer cells and prevent the disease's return for early stages and remission.I hope they're onto something real here.
An Israeli biotech company is developing a vaccine for cancer that it says can help prevent the return of the lethal disease for 90% of the differenttypes of cancer.
Vaxil BioTherapeutics based in Nes Ziona has been developing ImMucin for more than five years, and already has seen strong success in testing indicating it can be a vital tool in combating cancer. The disease kills eight million people worldwide per year, and sees 14 million new cases diagnosed annually according to the World Health Organization.
"Vaxil is developing a drug to keep the cancer from coming back," Vaxil's CFO Julian Levy told NoCamels. "We are trying to harness the natural power of the immune system to fight against cancer by seeking out cancer cells and destroying them."
. . .
The vaccine stimulates a certain part of the immune system, developing it to attack specific cells with markers indicating cancer. When used in early stages of cancer, the vaccine is expected to train the immune system to destroy the right cells as cancer develops and fight the disease.
Until last January the company focused its experiments on Multiple Myeloma patients, but then shifted to breast cancer patients. It may be some time before the vaccine sees its way onto the market though, with Levy expecting a release by 2020 at the latest.
How long before ISIS comes up with a cure for cancer?
No comments:
Post a Comment